Senécal J L, Rauch J
Department of Medicine, University of Montreal School of Medicine, Quebec, Canada.
Arthritis Rheum. 1988 Jul;31(7):864-75. doi: 10.1002/art.1780310707.
A panel of 65 systemic lupus erythematosus (SLE) and 61 normal-derived human hybridoma auto-antibodies was studied for cytoskeletal reactivity, using an indirect immunofluorescence method. Reactivity with the cytoskeleton was expressed 3 times more frequently in the SLE-derived antibody group and included intermediate filaments, microfilaments, microtubules, and centrioles. By immunoblot analysis, the antigenic specificity of intermediate filament-reactive SLE hybridoma antibodies was not restricted to vimentin, but included cytokeratins and desmin. The antibodies were also studied for their DNA-binding, lupus anticoagulant, and rheumatoid factor activities. These autoantibody activities were expressed 3-5 times more frequently in the SLE-derived group. The ability to bind DNA was not a prerequisite for reactivity with intermediate filament proteins. Our findings suggest that there are at least 2 subsets of cytoskeletal-reactive hybridoma antibodies: those that recognize epitopes found only on cytoskeletal proteins, and those that recognize epitopes common to both DNA and certain cytoskeletal proteins. In addition, we hypothesize that there may be a third subset of antibodies that recognize a phosphate-containing moiety (phospholipid or phosphoprotein) associated with cytoskeletal filaments.
使用间接免疫荧光法,对一组由65种系统性红斑狼疮(SLE)来源的和61种正常来源的人杂交瘤自身抗体进行了细胞骨架反应性研究。SLE来源的抗体组中与细胞骨架的反应性出现频率高出3倍,包括中间丝、微丝、微管和中心粒。通过免疫印迹分析,与中间丝反应的SLE杂交瘤抗体的抗原特异性不仅限于波形蛋白,还包括细胞角蛋白和结蛋白。还研究了这些抗体的DNA结合、狼疮抗凝物和类风湿因子活性。这些自身抗体活性在SLE来源的组中出现频率高出3至5倍。与中间丝蛋白反应的能力并非结合DNA的先决条件。我们的研究结果表明,至少有2个细胞骨架反应性杂交瘤抗体亚群:那些识别仅存在于细胞骨架蛋白上的表位的抗体,以及那些识别DNA和某些细胞骨架蛋白共有的表位的抗体。此外,我们推测可能存在第三个抗体亚群,其识别与细胞骨架细丝相关的含磷酸部分(磷脂或磷蛋白)。